Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWLotilaner is an isoxazoline ectoparasiticide.1,2 It is an antagonist of insect GABA-gated chloride channels (IC50 = 23.84 nM for the D. melanogaster channel) and is selective for insect channels over dog α1β2γ2 GABAA receptors at 10,000 nM.1 Lotilaner (20 mg/kg, p.o.) completely eliminates D. variabilis, R. sanguineus, A. americanum, and I. scapularis tick infestations in dogs after 48 hours.2 Formulations containing lotilaner have been used in the treatment of Demodex blepharitis and as veterinary anti-ectoparasitics.
WARNING This product is not for human or veterinary use.
1. The novel isoxazoline ectoparasiticide lotilaner (Credelio™): A non-
2. Laboratory evaluations of the immediate and sustained efficacy of lotilaner (Credelio™) against four common species of ticks affecting dogs in North America. Parasit. Vectors 10(1), 523 (2017).